BMO Capital Downgrades CVS Caremark (CVS) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $87.55 -0.22%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 17 | New: 36
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 17 | New: 36
Join SI Premium – FREE
BMO Capital downgraded CVS Caremark (NYSE: CVS) from Outperform to Market Perfor, maintains price target of $47.00.
For an analyst ratings summary and ratings history on CVS Caremark click here. For more ratings news on CVS Caremark click here.
Shares of CVS Caremark closed at $45.36 yesterday.
For an analyst ratings summary and ratings history on CVS Caremark click here. For more ratings news on CVS Caremark click here.
Shares of CVS Caremark closed at $45.36 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Huber Research double downgrades Netflix to underweight, sets $70 price target
- Aetna 2027 Star Ratings Reflect Strong Clinical Quality and Member Experience
- BofA Securities Downgrades Pershing Square Inc (PS) to Underperform
Create E-mail Alert Related Categories
DowngradesRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
